Prot# C-421: Phase II, Mltctr, Rndmzd, Dbl-Bld, Placebo-Cntrl'd Trial of Safety & Efficacy of CG53135-05 Administered Intravenously as a Single Dose for Prevention of Oral Mucositis in Patients Receiving Autologous Hematopoietic Stem Cell Transplant

Project: Research project

Project Details

StatusFinished
Effective start/end date4/5/0512/1/11

Funding

  • PPD Development (C-421)
  • CuraGen Corporation (C-421)